calendar
1 catalysts · 14 phase 2 completion · 8 phase 1 completion · 5 filing · 5 phase 2 initiation · 4 phase 1 2 completion · 4 phase 0 trial completion
next 91 dayslessmore
MonWedFri
1 catalysts · 14 phase 2 completion · 8 phase 1 completion · 5 filing · 5 phase 2 initiation · 4 phase 1 2 completion · 4 phase 0 trial completion
Therapy area: Cardiovascular, Gastrointestinal. Indication: Endothelial Dysfunction, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)